(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

REVANESSE OUTLINE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

REVANESSE OUTLINE

ST13

US500000090169231

Class

5

Filing

90169231

Registration

7498087

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

48

Latest update

09/10/2024

Classification

Registered

Trademark type

Word

Nice classes

5

Filing date

09/09/2020

Registration date

09/10/2024

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

09/10/2024

Last transaction

09/10/2024

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use, Foreign priority

Drawing code

4

Owner type

03

Owner location

Richmond Hill, Ontario, CA

Examiner

FITZSIMONS, MICHAEL R

Law office

L30

Current location

FILE REPOSITORY (FRANCONIA)

Holders and representatives

Holders

Prollenium Medical Technologies, Inc.

Representatives

Cassandra L. Wilkinson Head, Johnson, Kachigian & Wilkinson, PC

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations for the treatment of wrinkles; injectable dermal fillers; injectable gel for dermatological use for use in cosmetic surgerywound healing and non-surgical medical cosmetic treatment procedures; syringe containing gel for dermatological use for use in cosmetic surgerywound healing and non-surgical medical cosmetic treatment procedures

Publications

History of USPTO decisions and trademark events.

48 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

09/10/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

09/10/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

06/25/2024

PUBO

PUBLISHED FOR OPPOSITION

06/25/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

06/05/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

05/18/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

05/17/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/17/2024

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

05/17/2024

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

05/15/2024

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

03/04/2024

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

03/04/2024

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

03/04/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

03/04/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

03/04/2024

GNS2

NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED

02/24/2024

GNSI

INQUIRY TO SUSPENSION E-MAILED

02/24/2024

CNSI

SUSPENSION INQUIRY WRITTEN

02/24/2024

RCCK

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION

02/01/2024

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

01/24/2024

RCCK

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION

12/27/2023

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

04/21/2023

GNSL

LETTER OF SUSPENSION E-MAILED

04/21/2023

CNSL

SUSPENSION LETTER WRITTEN

04/21/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

04/12/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

04/12/2023

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

04/11/2023

GNS2

NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED

01/12/2023

GNSI

INQUIRY TO SUSPENSION E-MAILED

01/12/2023

CNSI

SUSPENSION INQUIRY WRITTEN

01/12/2023

RCCK

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION

12/05/2022

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

04/30/2022

GNSL

LETTER OF SUSPENSION E-MAILED

04/30/2022

CNSL

SUSPENSION LETTER WRITTEN

04/30/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

03/28/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/28/2022

ALIE

ASSIGNED TO LIE

03/27/2022

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

03/24/2022

GNS2

NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED

10/05/2021

GNSI

INQUIRY TO SUSPENSION E-MAILED

10/05/2021

CNSI

SUSPENSION INQUIRY WRITTEN

10/05/2021

RCCK

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION

09/03/2021

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

01/20/2021

GNSL

LETTER OF SUSPENSION E-MAILED

01/20/2021

CNSL

SUSPENSION LETTER WRITTEN

01/20/2021

DOCK

ASSIGNED TO EXAMINER

01/16/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

10/15/2020

NWAP

NEW APPLICATION ENTERED

09/12/2020

Continuous trademark protection

Get notified about every new filing that threatens REVANESSE OUTLINE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.